Despite Bumper Year, BLA Approvals Down in FY2011
By Mari Serebrov
Monday, November 7, 2011
WASHINGTON – Fiscal 2011 produced a bumper crop of new drug approvals with historic breakthroughs in a number of areas. But the yield on biologics actually dropped.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.